The current rise in the prevalence of magnetic resonance spectroscopy experiments to measure γ-aminobutyric acid in the living human brain is an exciting and productive area of research. As research spreads into clinical populations and cognitive research, it is important to fully understand the source of the magnetic resonance spectroscopy signal and apply appropriate interpretation to the results of the experiments. γ-aminobutyric acid is present in the brain not only as a neurotransmitter, but also in high intracellular concentrations, both as a transmitter precursor and a metabolite. γ-aminobutyric acid concentrations measured by magnetic resonance spectroscopy are not necessarily implicated in neurotransmission and therefore may reflect a very different brain activity to that commonly suggested. In this perspective, we examine some of the considerations to be taken in the interpretation of any γ-aminobutyric acid signal measured by magnetic resonance spectroscopy.
AngehagenMBen-MenachemERonnbackL. (2003) Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate. Neurochem Res28: 333–340.
2.
ApostolidesPFTrussellLO (2013) Regulation of interneuron excitability by gap junction coupling with principal cells. Nat Neurosci16: 1764–1772.
3.
AxmacherNDraguhnA (2004) Inhibition of GABA release by presynaptic ionotropic GABA receptors in hippocampal CA3. Neuroreport15: 329–334.
4.
BalazsRMachiyamaYHammondBJ. (1970) The operation of the gamma-aminobutyrate bypath of the tricarboxylic acid cycle in brain tissue in vitro. Biochem J116: 445–461.
5.
BarakatLBordeyA (2002) GAT-1 and reversible GABA transport in Bergmann glia in slices. J Neurophysiol88: 1407–1419.
6.
BattaglioliGMartinDL (1991) GABA synthesis in brain slices is dependent on glutamine produced in astrocytes. Neurochem Res16: 151–156.
7.
Ben-MenachemE (1995) International experience with tiagabine add-on therapy. Epilepsia36 (Suppl. 6): S14–S21.
BrambillaPStanleyJANicolettiM. (2002) 1H MRS brain measures and acute lorazepam administration in healthy human subjects. Neuropsychopharmacology26: 546–551.
10.
CammackJNRakhilinSVSchwartzEA (1994) A GABA transporter operates asymmetrically and with variable stoichiometry. Neuron13: 949–960.
11.
CavelierPHamannMRossiD. (2005) Tonic excitation and inhibition of neurons: ambient transmitter sources and computational consequences. Prog Biophys Mol Biol87: 3–16.
12.
CletonADe GreefHJEdelbroekPM. (1999) Application of a combined “effect compartment/indirect response model” to the central nervous system effects of tiagabine in the rat. J Pharmacokinet Biopharm27: 301–323.
13.
ContiFMeloneMFattoriniG. (2011) A Role for GAT-1 in Presynaptic GABA Homeostasis?Front Cell Neurosci5: 2.
14.
CousijnHHaegensSWallisG. (2014) Resting GABA and glutamate concentrations do not predict visual gamma frequency or amplitude. Proc Natl Acad Sci U S A111: 9301–9306.
15.
DekenSLWangDQuickMW (2003) Plasma membrane GABA transporters reside on distinct vesicles and undergo rapid regulated recycling. J Neurosci23: 1563–1568.
16.
DingledineRKornSJ (1985) Gamma-aminobutyric acid uptake and the termination of inhibitory synaptic potentials in the rat hippocampal slice. J Physiol366: 387–409.
17.
DuringMMattsonRHScheyerRD. (1992) The effect of tiagabine HCl on extracellular GABA levels in the human hippocampus. Epilepsia33(Suppl. 3): 83.
18.
Fink-JensenASuzdakPDSwedbergMD. (1992) The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats. Eur J Pharmacol220: 197–201.
19.
GoddardAWMasonGFAppelM. (2004) Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am J Psychiatry161: 2186–2193.
20.
HarrisADPutsNAAndersonBA. (2015) Multi-regional investigation of the relationship between functional MRI blood oxygenation level dependent (BOLD) activation and GABA concentration. PLoS One10: e0117531.
21.
IsaacsonJSSolisJMNicollRA (1993) Local and diffuse synaptic actions of GABA in the hippocampus. Neuron10: 165–175.
22.
JacksonMFEsplinBCapekR (1999) Inhibitory nature of tiagabine-augmented GABAA receptor-mediated depolarizing responses in hippocampal pyramidal cells. J Neurophysiol81: 1192–1198.
23.
KaufmanDLHouserCRTobinAJ (1991) Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem56: 720–723.
KuznieckyRHoSPanJ. (2002) Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology58: 368–372.
26.
LicataSCJensenJEPenetarDM. (2009) A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T. Psychopharmacology (Berl)203: 819–829.
27.
MattsonRHPetroffOARothmanD. (1995) Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy. Acta Neurol Scand162(Suppl.): 27–30.
28.
MescherMMerkleHKirschJ. (1998) Simultaneous in vivo spectral editing and water suppression. NMR Biomed11: 266–272.
29.
MuthukumaraswamySDEddenRAJonesDK. (2009) Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans. Proc Natl Acad Sci U S A106: 8356–8361.
30.
MuthukumaraswamySDMyersJFWilsonSJ. (2013) Elevating endogenous GABA levels with GAT-1 blockade modulates evoked but not induced responses in human visual cortex. Neuropsychopharmacology38: 1105–1112.
31.
MuthukumaraswamySDMyersJFWilsonSJ. (2012) The effects of elevated endogenous GABA levels on movement-related network oscillations. NeuroImage66C: 36–41.
32.
MyersJFEvansCJKalkNJ. (2014) Measurement of GABA using J-difference edited 1H-MRS following modulation of synaptic GABA concentration with tiagabine. Synapse68: 355–362.
33.
OlsenRWSieghartW (2008) International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev60: 243–260.
34.
OverstreetLSWestbrookGL (2001) Paradoxical reduction of synaptic inhibition by vigabatrin. J Neurophysiol86: 596–603.
35.
PatelABDe GraafRARothmanDL. (2015) Effects of gamma-Aminobutyric acid transporter 1 inhibition by tiagabine on brain glutamate and gamma-Aminobutyric acid metabolism in the anesthetized rat In vivo. J Neurosci Res93: 1101–1108.
36.
PetroffOAHyderFMattsonRH. (1999a) Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy. Neurology52: 473–478.
37.
PetroffOARothmanDLBeharKL. (1999b) Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures. Seizure8: 120–127.
38.
PollackMHJensenJESimonNM. (2008) High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry32: 739–743.
39.
PutsNAEddenRA (2012) In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc60: 29–41.
40.
SloviterRSDichterMARachinskyTL. (1996) Basal expression and induction of glutamate decarboxylase and GABA in excitatory granule cells of the rat and monkey hippocampal dentate gyrus. J Comp Neurol373: 593–618.
41.
StaggCJBachtiarVJohansen-BergH (2011) What are we measuring with GABA magnetic resonance spectroscopy?Commun Integr Biol4: 573–575.
42.
StaggCJBestJGStephensonMC. (2009a) Polarity-sensitive modulation of cortical neurotransmitters by transcranial stimulation. J Neurosci29: 5202–5206.
43.
StaggCJWylezinskaMMatthewsPM. (2009b) Neurochemical effects of theta burst stimulation as assessed by magnetic resonance spectroscopy. J Neurophysiol101: 2872–2877.
44.
StokesPRMyersJFKalkNJ. (2014) Acute increases in synaptic GABA detectable in the living human brain: A [(11)C]Ro15–4513 PET study. NeuroImage99: 158–165.
45.
VerhoeffNPPetroffOAHyderF. (1999) Effects of vigabatrin on the GABAergic system as determined by [123I]iomazenil SPECT and GABA MRS. Epilepsia40: 1433–1438.
46.
WaagepetersenHSBakkenIJLarssonOM. (1998) Metabolism of lactate in cultured GABAergic neurons studied by 13C nuclear magnetic resonance spectroscopy. J Cereb Blood Flow Metab18: 109–117.
47.
WaagepetersenHSSonnewaldUSchousboeA (1999) The GABA paradox: multiple roles as metabolite, neurotransmitter, and neurodifferentiative agent. J Neurochem73: 1335–1342.
48.
WallsABWaagepetersenHSBakLK. (2015) The glutamine-glutamate/GABA cycle: function, regional differences in glutamate and GABA production and effects of interference with GABA metabolism. Neurochem Res40: 402–409.
49.
WeberOMVerhagenADucCO. (1999) Effects of vigabatrin intake on brain GABA activity as monitored by spectrally edited magnetic resonance spectroscopy and positron emission tomography. Magn Reson Imaging17: 417–425.
50.
WuYWangWDiez-SampedroA. (2007) Nonvesicular inhibitory neurotransmission via reversal of the GABA transporter GAT-1. Neuron56: 851–865.
51.
ZaleskaMMErecinskaM (1987) Role of sialic acid in synaptosomal transport of amino acid transmitters. Proc Natl Acad Sci U S A84: 1709–1712.
